Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Top Cited Papers
Open Access
- 28 January 2016
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 164 (4), 770-779
- https://doi.org/10.1016/j.cell.2016.01.011
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic LeukemiaScience Translational Medicine, 2013
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene TherapyJournal of Immunotherapy, 2013
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in miceJCI Insight, 2010
- Designing customized cell signalling circuitsNature Reviews Molecular Cell Biology, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Engineering lymphocyte subsets: tools, trials and tribulationsNature Reviews Immunology, 2009
- Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical ExperienceJournal of Clinical Oncology, 2006